NEU S&P DJI Announces March 2021 Quarterly Rebalance 12/03/21 PRICE SENSITIVE download Created with Sketch. 183.24KB Share NEU Neuren successfully completes manufacturing for Phase 2 10/03/21 PRICE SENSITIVE download Created with Sketch. 183.13KB Share NEU Neuren approaching transforming milestones in 2021 24/02/21 PRICE SENSITIVE download Created with Sketch. 163.7KB Share NEU Preliminary Final Report and 2020 full year accounts 24/02/21 PRICE SENSITIVE download Created with Sketch. 508.05KB Share NEU Neuren adds Prader-Willi syndrome to NNZ-2591 pipeline 16/02/21 PRICE SENSITIVE download Created with Sketch. 225KB Share NEU Successful Phase 1 trial for Neuren's NNZ-2591 15/02/21 PRICE SENSITIVE download Created with Sketch. 153.49KB Share NEU Quarterly report and cash flow statement for Q4 2020 29/01/21 PRICE SENSITIVE download Created with Sketch. 204.13KB Share NEU European Commission grants 3 NNZ-2591 Orphan designations 11/01/21 PRICE SENSITIVE download Created with Sketch. 143.44KB Share NEU Positive opinion for all 3 Orphan applications in Europe 07/12/20 PRICE SENSITIVE download Created with Sketch. 145.2KB Share NEU Approval received for final stage of NNZ-2591 clinical trial 19/11/20 PRICE SENSITIVE download Created with Sketch. 129.76KB Share NEU Quarterly report and cash flow statement for Q3 2020 29/10/20 PRICE SENSITIVE download Created with Sketch. 265.24KB Share NEU Neuren initiates manufacture of NNZ-2591 for Phase 2 trials 22/09/20 PRICE SENSITIVE download Created with Sketch. 142.98KB Share NEU Half Yearly Report and Accounts 26/08/20 PRICE SENSITIVE download Created with Sketch. 274.21KB Share NEU Q2 2020 Activity Report and Cash Flow Report 27/07/20 PRICE SENSITIVE download Created with Sketch. 193.97KB Share NEU Proposed issue of Securities - NEU 29/06/20 PRICE SENSITIVE download Created with Sketch. 33.15KB Share NEU Neuren successfully completes $20m capital raising 29/06/20 PRICE SENSITIVE download Created with Sketch. 131.12KB Share NEU Trading Halt 25/06/20 PRICE SENSITIVE download Created with Sketch. 160.11KB Share NEU Temporary enrolment pause ended in Phase 3 trial in the US 16/06/20 PRICE SENSITIVE download Created with Sketch. 242.24KB Share NEU Neuren announces changes to leadership team 27/05/20 PRICE SENSITIVE download Created with Sketch. 132.46KB Share NEU Neuren commences first clinical trial for NNZ-2591 07/05/20 PRICE SENSITIVE download Created with Sketch. 121.9KB Share NEU Appendix 4C - quarterly 17/04/20 PRICE SENSITIVE download Created with Sketch. 55.99KB Share NEU Q1 2020 Activity Report 17/04/20 PRICE SENSITIVE download Created with Sketch. 131.81KB Share NEU First patent in Israel granted for trofinetide 02/04/20 PRICE SENSITIVE download Created with Sketch. 118.28KB Share NEU Temporary pause in new enrolments for LAVENDER trial in US 24/03/20 PRICE SENSITIVE download Created with Sketch. 198.24KB Share NEU Trading Halt 20/03/20 PRICE SENSITIVE download Created with Sketch. 145.49KB Share NEU Neuren to capture substantially greater value after Phase 3 17/03/20 PRICE SENSITIVE download Created with Sketch. 138.58KB Share NEU Compelling results for 2591 dose ranging study in PMS model 06/03/20 PRICE SENSITIVE download Created with Sketch. 184.18KB Share NEU Commentary on potential benefit to Neuren of RPD designation 04/03/20 PRICE SENSITIVE download Created with Sketch. 154.06KB Share NEU Rare Pediatric Disease designation received from FDA 04/03/20 PRICE SENSITIVE download Created with Sketch. 182.01KB Share NEU Appendix 4E and 2019 full year accounts 26/02/20 PRICE SENSITIVE download Created with Sketch. 1.15MB Share NEU Update on trofinetide Phase 3 trial in Rett syndrome 19/02/20 PRICE SENSITIVE download Created with Sketch. 101.14KB Share NEU Appendix 4C - quarterly 28/01/20 PRICE SENSITIVE download Created with Sketch. 47.49KB Share NEU 2019 year-end update and 2020 outlook 12/12/19 PRICE SENSITIVE download Created with Sketch. 125.65KB Share NEU Patent to 2034 granted in Europe for Neuren's NNZ-2591 03/12/19 PRICE SENSITIVE download Created with Sketch. 122.35KB Share NEU Phase 3 trial of trofinetide in Rett syndrome commences 31/10/19 PRICE SENSITIVE download Created with Sketch. 332.86KB Share NEU Appendix 4C - quarterly 17/10/19 PRICE SENSITIVE download Created with Sketch. 47.73KB Share NEU FDA grants Orphan for both Phelan-McDermid and Pitt Hopkins 16/10/19 PRICE SENSITIVE download Created with Sketch. 121.85KB Share NEU Pause in Trading 16/10/19 PRICE SENSITIVE download Created with Sketch. 117.01KB Share NEU FDA grants Orphan Drug Designation for NNZ-2591 in Angelman 11/10/19 PRICE SENSITIVE download Created with Sketch. 120.99KB Share NEU Neuren approaching key milestones in Q4 2019 20/09/19 PRICE SENSITIVE download Created with Sketch. 122.21KB Share NEU Half Yearly Report and Accounts 28/08/19 PRICE SENSITIVE download Created with Sketch. 1.37MB Share NEU Appendix 4C - quarterly 31/07/19 PRICE SENSITIVE download Created with Sketch. 140.75KB Share NEU NNZ-2591 positive effects in Pitt Hopkins syndrome model 17/05/19 PRICE SENSITIVE download Created with Sketch. 121.68KB Share NEU NNZ-2591 positive effects in Angelman syndrome model 17/05/19 PRICE SENSITIVE download Created with Sketch. 121.73KB Share NEU Appendix 4C - quarterly 30/04/19 PRICE SENSITIVE download Created with Sketch. 48.3KB Share NEU Update on development plan for NNZ-2591 26/04/19 PRICE SENSITIVE download Created with Sketch. 131.77KB Share NEU Neuren's Rett syndrome Phase 2 trial published in Neurology 28/03/19 PRICE SENSITIVE download Created with Sketch. 239.68KB Share NEU Preliminary Final Report and statutory accounts 27/02/19 PRICE SENSITIVE download Created with Sketch. 458.14KB Share NEU NNZ-2591 positive effects in Phelan-McDermid syndrome model 18/02/19 PRICE SENSITIVE download Created with Sketch. 109KB Share NEU Appendix 4C - quarterly 31/01/19 PRICE SENSITIVE download Created with Sketch. 47.82KB Share NEU Appendix 4C - quarterly 31/10/18 PRICE SENSITIVE download Created with Sketch. 75.3KB Share NEU Trofinetide ex-North America exclusive negotiation period 26/10/18 PRICE SENSITIVE download Created with Sketch. 100.3KB Share NEU Half Yearly Report and Accounts 31/08/18 PRICE SENSITIVE download Created with Sketch. 713.9KB Share NEU Neuren and Lanstead agree to pause settlements for 120 days 29/08/18 PRICE SENSITIVE download Created with Sketch. 102.56KB Share NEU Neuren receives initial payment of US$10 million from ACADIA 22/08/18 PRICE SENSITIVE download Created with Sketch. 119.21KB Share NEU Neuren and ACADIA announce agreement for North America 07/08/18 PRICE SENSITIVE download Created with Sketch. 222.12KB Share NEU Appendix 4C - quarterly 31/07/18 PRICE SENSITIVE download Created with Sketch. 47.69KB Share NEU Announcement of buy-back - Appendix 3C 30/05/18 PRICE SENSITIVE download Created with Sketch. 74.27KB Share NEU Neuren announces investment and exclusive negotiation period 21/05/18 PRICE SENSITIVE download Created with Sketch. 99.49KB Share NEU Appendix 4C - quarterly 30/04/18 PRICE SENSITIVE download Created with Sketch. 62.65KB Share NEU First patent in Japan granted for Neuren's trofinetide 30/04/18 PRICE SENSITIVE download Created with Sketch. 99.59KB Share NEU Disclosure under Listing Rule 4.3D 29/03/18 PRICE SENSITIVE download Created with Sketch. 132.17KB Share NEU S&P DJ Indices Announces March Quarterly Rebalance 09/03/18 PRICE SENSITIVE download Created with Sketch. 201.26KB Share NEU Preliminary Final Report 28/02/18 PRICE SENSITIVE download Created with Sketch. 65.52KB Share NEU Appendix 4C - quarterly 30/01/18 PRICE SENSITIVE download Created with Sketch. 47.77KB Share NEU Neuren announces new US patent to be granted for NNZ-2591 05/12/17 PRICE SENSITIVE download Created with Sketch. 103.84KB Share NEU Consolidation/Split - NEU 16/11/17 PRICE SENSITIVE download Created with Sketch. 25.08KB Share NEU Appendix 4C - quarterly 26/10/17 PRICE SENSITIVE download Created with Sketch. 48.91KB Share NEU Neuren FDA meeting confirms Phase 3 plan for Rett syndrome 13/10/17 PRICE SENSITIVE download Created with Sketch. 102.03KB Share NEU Presentations and publication for Rett syndrome trials 05/10/17 PRICE SENSITIVE download Created with Sketch. 108.16KB Share NEU Half Yearly Report and Accounts 24/08/17 PRICE SENSITIVE download Created with Sketch. 1.29MB Share NEU Appendix 4C - quarterly 27/07/17 PRICE SENSITIVE download Created with Sketch. 74.29KB Share NEU Neuren granted Type B Meeting with FDA for Rett syndrome 20/07/17 PRICE SENSITIVE download Created with Sketch. 100.95KB Share NEU Neuren secures funding for key activities for Rett syndrome 29/06/17 PRICE SENSITIVE download Created with Sketch. 121.62KB Share NEU Response to ASX Price Query 28/06/17 PRICE SENSITIVE download Created with Sketch. 429.31KB Share NEU Trading Halt 27/06/17 PRICE SENSITIVE download Created with Sketch. 307.79KB Share NEU Neuren announces grant of two new patents to 2032 31/05/17 PRICE SENSITIVE download Created with Sketch. 103.2KB Share NEU Response to Appendix 4C Query 08/05/17 PRICE SENSITIVE download Created with Sketch. 434.08KB Share NEU Appendix 4C - quarterly 28/04/17 PRICE SENSITIVE download Created with Sketch. 71.59KB Share NEU Neuren receives $1 million R&D Tax Incentive 04/04/17 PRICE SENSITIVE download Created with Sketch. 97.8KB Share NEU Trofinetide significant clinical benefit in Rett syndrome 22/03/17 PRICE SENSITIVE download Created with Sketch. 727.42KB Share NEU Trading Halt 17/03/17 PRICE SENSITIVE download Created with Sketch. 306.42KB Share NEU S&P DJ Indices Announces March Quarterly Rebalance 10/03/17 PRICE SENSITIVE download Created with Sketch. 177.37KB Share NEU Preliminary Final Report 23/02/17 PRICE SENSITIVE download Created with Sketch. 90.75KB Share NEU Appendix 4C - quarterly 31/01/17 PRICE SENSITIVE download Created with Sketch. 71.9KB Share NEU Neuren completes Phase 2 trial in pediatric Rett syndrome 30/01/17 PRICE SENSITIVE download Created with Sketch. 115.21KB Share NEU Notice of special meeting of shareholders 14/11/16 PRICE SENSITIVE download Created with Sketch. 523.49KB Share NEU Neuren completes enrolment in Rett syndrome Phase 2 trial 14/11/16 PRICE SENSITIVE download Created with Sketch. 116.39KB Share NEU Appendix 4C - quarterly-NEU.AX 31/10/16 PRICE SENSITIVE download Created with Sketch. 74.31KB Share NEU Neuren receives $0.9m from exercise of last expiring options-NEU.AX 28/10/16 PRICE SENSITIVE download Created with Sketch. 102.44KB Share NEU Half Yearly Report and Accounts-NEU.AX 30/08/16 PRICE SENSITIVE download Created with Sketch. 459.62KB Share NEU Neuren expands Phase 2 Rett syndrome pediatric trial-NEU.AX 28/08/16 PRICE SENSITIVE download Created with Sketch. 121.69KB Share NEU Neuren expands Phase 2 Rett syndrome pediatric trial-NEU.AX 25/08/16 PRICE SENSITIVE download Created with Sketch. 121.69KB Share NEU Appendix 4C - quarterly-NEU.AX 26/07/16 PRICE SENSITIVE download Created with Sketch. 55.42KB Share NEU Neuren presents at Rettsyndrome.org 2016 Research Symposium-NEU.AX 24/06/16 PRICE SENSITIVE Share NEU Neuren presents at Rettsyndrome.org 2016 Research Symposium-NEU.AX 24/06/16 PRICE SENSITIVE download Created with Sketch. 1.93MB Share NEU Grant of new patent for Autism Spectrum Disorders-NEU.AX 22/06/16 PRICE SENSITIVE download Created with Sketch. 103.21KB Share NEU Appendix 4C - quarterly-NEU.AX 29/04/16 PRICE SENSITIVE download Created with Sketch. 55.33KB Share NEU Results of Phase 2 trial in moderate to severe TBI-NEU.AX 26/04/16 PRICE SENSITIVE download Created with Sketch. 114.81KB Share NEU Trading Halt-NEU.AX 22/04/16 PRICE SENSITIVE download Created with Sketch. 315.99KB Share
(20min delay)
